Meme kanserli kadınlarda adjuvan tamoksifen tedavisinin serum lipid ve lipoprotein düzeylerine etkisi
The Effect of adjuvant tamoxifen on serum lipid and lipoprotein levels in women with breast cancer
- Tez No: 38175
- Danışmanlar: PROF.DR. NECDET ÜSKENT
- Tez Türü: Tıpta Uzmanlık
- Konular: Endokrinoloji ve Metabolizma Hastalıkları, Endocrinology and Metabolic Diseases
- Anahtar Kelimeler: Belirtilmemiş.
- Yıl: 1994
- Dil: Türkçe
- Üniversite: GATA
- Enstitü: Haydarpaşa Eğitim Hastanesi
- Ana Bilim Dalı: Belirtilmemiş.
- Bilim Dalı: Belirtilmemiş.
- Sayfa Sayısı: 40
Özet
SUMMARY The Effect of Adjuvant Tamoxifen on Serum Lipid and Lipoprotein Levels in Women with Breast Cancer A number of studies have been arranged about the adjuvant Tamoxifen (TAM) therapy in breast cancer for both the therapeutic activity of the drug and the influences on serum lipid and lipoprotein levels, considered as its potential positive side effects. M mis study, the effects of TAM on serum lipids and lipoproteins were compared in both pre- and post-treatment sera and the medical benefits of the results were discussed, A total of 31 women with breast cancer ( 11 premenopausal, 20 postmenopausal ) were included in the study. The serum levels of TC, LDLC, HDLC, TG, APO A-I, APO A-fl, APO B and total estradiol were determined before TAM therapy. After the initiation of TAM ( 10 mg, bid ), the serum levels of the same parameters determined on the 3rd, 6th, 9th and 12th months were all compared to the original results. The serum levels of TC and LDLC decreased in all patients. This decrement was statistically significant (p0.05), a statistically significant increment was determined in postmenopausal group (p0.05). v>We have determined that serum APO A-I and APO A-II levels increased (40 %) and APO B levels decreased (22 %) at the end of TAM therapy. When compared to the basal values, APO A-I/APO B ratio has been found to increase (78 %). All these changes have been found to be statistically significant (p0.05). m the light of these results, we conclude that TAM influences the serum lipid and lipoprotein levels positively, with its partial agonistic effects similar to estrogen. Thus, besides the beneficial effects on breast cancer, TAM prevents the development of coronary heart disease. ?n
Özet (Çeviri)
SUMMARY The Effect of Adjuvant Tamoxifen on Serum Lipid and Lipoprotein Levels in Women with Breast Cancer A number of studies have been arranged about the adjuvant Tamoxifen (TAM) therapy in breast cancer for both the therapeutic activity of the drug and the influences on serum lipid and lipoprotein levels, considered as its potential positive side effects. M mis study, the effects of TAM on serum lipids and lipoproteins were compared in both pre- and post-treatment sera and the medical benefits of the results were discussed, A total of 31 women with breast cancer ( 11 premenopausal, 20 postmenopausal ) were included in the study. The serum levels of TC, LDLC, HDLC, TG, APO A-I, APO A-fl, APO B and total estradiol were determined before TAM therapy. After the initiation of TAM ( 10 mg, bid ), the serum levels of the same parameters determined on the 3rd, 6th, 9th and 12th months were all compared to the original results. The serum levels of TC and LDLC decreased in all patients. This decrement was statistically significant (p0.05), a statistically significant increment was determined in postmenopausal group (p0.05). v>We have determined that serum APO A-I and APO A-II levels increased (40 %) and APO B levels decreased (22 %) at the end of TAM therapy. When compared to the basal values, APO A-I/APO B ratio has been found to increase (78 %). All these changes have been found to be statistically significant (p0.05). m the light of these results, we conclude that TAM influences the serum lipid and lipoprotein levels positively, with its partial agonistic effects similar to estrogen. Thus, besides the beneficial effects on breast cancer, TAM prevents the development of coronary heart disease. ?n
Benzer Tezler
- Meme kanserinde adjuvan tamoksifen tedavisinin postmenopozal hastalarda serum lipid ve lipoproteinlerine etkisi
The Effect of adjuvant tamoxifen treatment on serum lipid and lipoprotein levels in postmenopausal with breast cancer
SABRİ BARUTCA
Tıpta Uzmanlık
Türkçe
1999
HematolojiDokuz Eylül ÜniversitesiHematoloji Ana Bilim Dalı
PROF. DR. MEHMET NİYAZİ ALAKAVUKLAR
- Premenopozal meme kanserli kadınlarda adjuvan tamoksifen ile tamoksifen ve gnrh analoglarının birlikte kullanımının tedavi etkinliği açısından kıyaslanması
Compari̇son between the treatment outcomes of use of tamoxi̇fen and concurrent use of tamoxi̇fen wi̇th gnrh analouges as adjuvant i̇n breast cancer
GÜLGÜN ÖZBEK
Tıpta Uzmanlık
Türkçe
2017
OnkolojiNecmettin Erbakan Üniversitesiİç Hastalıkları Ana Bilim Dalı
PROF. DR. MEHMET ARTAÇ
- Hormon reseptör pozitif erken evre meme kanserinde adjuvan hormonal tedavinin depresyon, uyku kalitesi ve cinsel fonksiyon üzerine etkinliğinin araştırılması
Investigation of the effectiveness of adjuvant hormonal treatment on depression, sleep quality and sexual function in hormone receptor positive early stage breast cancer
YAĞMUR KINACI GÜMÜŞÇUBUK
Tıpta Uzmanlık
Türkçe
2020
OnkolojiAnkara Yıldırım Beyazıt Üniversitesiİç Hastalıkları Ana Bilim Dalı
DOÇ. DR. MEHMET ALİ NAHİT ŞENDUR
- Pre/post menapozal erken evre adjuvan kemoterapilerini tamamlamış, endokrin tedavi almakta olan, aromataz inhibitörü kullanan meme kanserli hastalarda miyalji ve artraljinin yaptığı fonksiyon kaybı
Loss of function done by arthalgia and myalgia in pre/post menopausal breast cancer patients who had completed the early stages of adjuvant chemotherapy, receving endocrine therapy and use aromatase inhibitors.
SABİYE ÖZGE ÖZGEN
Yüksek Lisans
Türkçe
2010
OnkolojiÇukurova Üniversitesiİç Hastalıkları Ana Bilim Dalı
PROF. DR. BERKSOY ŞAHİN
- Meme kanseri: Birinci basamakta hormonoterapi yan etkileri hakkında önemli noktalar
Breast cancer the hormonal terapy important points about side effects in the primary care
ALPER DURMUŞ SÖNMEZ
Tıpta Uzmanlık
Türkçe
2014
Aile Hekimliğiİzmir Katip Çelebi ÜniversitesiAile Hekimliği Ana Bilim Dalı
YRD. DOÇ. DR. HÜSEYİN CAN
DOÇ. DR. AHMET ALACACIOĞLU